Interplay between transcription factors and the epigenome: Insight from the role of RUNX1 in leukemia.
The genome has the ability to respond in a precise and co-ordinated manner to cellular signals. It achieves this through the concerted actions of transcription factors and the chromatin platform, which are targets of the signalling pathways. Our understanding of the molecular mechanisms through whic...
Main Authors: | Kate Helen Brettingham-Moore, Phillippa Claire Taberlay, Adele Frances Holloway |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00499/full |
Similar Items
-
RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia
by: Emiel van der Kouwe, et al.
Published: (2019-01-01) -
Sperm epigenomics: challenges and opportunities
by: Tanya eVavouri, et al.
Published: (2014-09-01) -
RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML
by: Justin Loke, et al.
Published: (2017-05-01) -
Molecular Monitoring of RUNX1-RUNX1T1 Transcript Level in Acute Myeloblastic Leukemias on Treatment
by: LL Girshova, et al.
Published: (2016-10-01) -
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
by: Giorgio Milazzo, et al.
Published: (2020-05-01)